Apogee Therapeutics, Inc. (APGE) Financials

APGE Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 1.3 billion 37.9 million
Dec. 31, 2025 937.1 million 33.3 million
Sept. 30, 2025 626.2 million 39.8 million
June 30, 2025 657.8 million 38.4 million

APGE Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -55.6 million 17.2 million
Dec. 31, 2025 -62.8 million 11.9 million
Sept. 30, 2025 -54.3 million 11.9 million
June 30, 2025 -62.8 million 11.3 million

APGE Net Income

No data available :(

APGE Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 1.1 billion 4.9 million -
Dec. 31, 2025 730.2 million 5.3 million 8.8 million
Sept. 30, 2025 527.3 million - 9.9 million
June 30, 2025 505.4 million - 6.8 million

APGE Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 69.7 million
Dec. 31, 2025 60.7 million
Sept. 30, 2025 58.8 million
June 30, 2025 58.4 million

APGE Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 60.8 million 21.5 million -408000
Dec. 31, 2025 62000 58.4 million 20.1 million -
Sept. 30, 2025 - 54.2 million 17.1 million -
June 30, 2025 768000 55.7 million 17.1 million -

APGE Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 408000
Dec. 31, 2025 - -400000
Sept. 30, 2025 - 400000
June 30, 2025 - 400000

APGE

Price: $86.19

52 week price:
34.34
95.32

Earnings Per Share: -4.33 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 5.1 billion

Links: